Investor Presentaiton

Investor presentation Full year 2018 Solid sales growth driven by diabetes care and obesity Slide 106 DKK billion Reported annual sales 2014-2018 Diabetes and obesity care Reported annual sales split by region North America Biopharmaceuticals Region China Region Europe Region J&K Region AAMEO Region LATAM CAGR¹ 4.7% 120 3% 4% 6% 5% 100 20% 17% 16% 9% 10% 21% 11% 11% 80 21% 23% 19% 60 84% 83% 79% 80% 40 79% 49% 51% 20 0 2014 2015 2016 2017 2018 2014 2018 1 CAGR for 5-year period changing diabetes AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan and Korea; LATAM: Latin America novo nordisk

View entire presentation